Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib and Carboplatin in Recurrent Ovarian Cancer
NCT00030446Phase 2Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Jan 2002
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in ovarian epithelial cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Canadian Cancer Trials Group. Started Jan 2002; status: completed.
02
Drugs
erlotinib
03
Conditions
ovarian epithelial cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00030446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00030446.